World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
53221
World Ranking
7215
National Ranking
702

Keith Wheatley publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Keith Wheatley sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 396 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Keith Wheatley D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Keith Wheatley sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 103 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Keith Wheatley is affiliated with the University of Birmingham in the United Kingdom. Their research primarily falls within the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a notable focus on Pulmonary and Respiratory Medicine, Neurology, Genetics, Oncology, and Molecular Biology.

The scientist's main research topics include Lymphoma Diagnosis and Treatment, Sarcoma Diagnosis and Treatment, Neuroblastoma Research and Treatments, Cancer therapeutics and mechanisms, Cancer, Hypoxia, and Metabolism, Glioma Diagnosis and Treatment, and Chronic Lymphocytic Leukemia Research.

Frequent publication venues for their work are:

  • Journal of Clinical Oncology
  • Cancers
  • Journal of Neuro-Oncology
  • Blood
  • Clinical Cancer Research

Several recent papers associated with Wheatley's research include:

  • Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children, 2020, New England Journal of Medicine
  • Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia, 2020, Journal of Clinical Oncology
  • International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol, 2020, Trials
  • Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial, 2022, The Lancet
  • Randomized Phase II Trial of Vincristine-Irinotecan With or Without Temozolomide, in Children and Adults With Relapsed or Refractory Rhabdomyosarcoma: A European Paediatric Soft Tissue Sarcoma Study Group and Innovative Therapies for Children With Cancer Trial, 2021, Journal of Clinical Oncology

Wheatley has collaborated with multiple frequent co-authors, including:

  • Cormac Owens
  • Pamela Kearns
  • Nicola Fenwick
  • Natasha K. A. van Eijkelenburg
  • Nathalie Gaspar

The scope of Wheatley's research demonstrates engagement with clinical oncology topics and childhood cancers, as well as varied aspects of cancer biology and treatment approaches. The multidisciplinary contributions across clinical and molecular studies highlight a comprehensive approach to cancer research.

Best Publications

  • Mortality in relation to smoking: 50 years' observations on male British doctors

    Richard Doll;Richard Peto;Jillian Boreham;Isabelle Sutherland

  • The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial

    David Grimwade;Helen Walker;Fiona Oliver;Keith Wheatley

  • Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

    Robert A. Kyle;J. Anthony Child;Kenneth Anderson;Bart Barlogie

  • The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials.

    Panagiotis D. Kottaridis;Rosemary E. Gale;Marion E. Frew;Georgina Harrison

  • Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials

    David Grimwade;Robert K. Hills;Anthony V. Moorman;Helen Walker

  • Randomised trial of prophylactic daily aspirin in British male doctors

    R Peto;R Gray;R Collins;K Wheatley

  • Association between premature mortality and hypopituitarism

    J. W. Tomlinson;N. Holden;Robert Kerrin Hills;K. Wheatley

  • Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors

    Richard Doll;R. Peto;E. Hall;K. Wheatley

  • Hydroxyurea Compared with Anagrelide in High-Risk Essential Thrombocythemia

    Harrison Cn;Campbell Pj;Buck G;Wheatley K

  • The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.

    David Grimwade;Helen Walker;Georgina Harrison;Fiona Oliver

  • Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study

    Peter J Campbell;Linda M Scott;Georgina Buck;Keith Wheatley

  • Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial

    Adrian J Williams;Steven R. Gill;Thelekat Varma;Crispin Jenkinson

  • Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial

    Alan Kenneth Burnett;Anthony H. Goldstone;Richard M. F. Stevens;Ian M. Hann

  • A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment†‡

    Alan Kenneth Burnett;Donald Milligan;Archie G. Prentice;Anthony H. Goldstone

  • Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial

    Alan Kenneth Burnett;Robert Kerrin Hills;Donald Milligan;Lars Kjeldsen

  • Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6,633 patients from 27 randomized trials

    S Pasquali;J D Maqueo;J Vela;R A Kyle

  • A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties.

    Keith Wheatley;Alan Kenneth Burnett;Anthony H. Goldstone;Richard G. Gray

  • Physiotherapy versus placebo or no intervention in Parkinson's disease

    Claire L Tomlinson;Smitaa Patel;Charmaine Meek;Clare P Herd

  • Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial.

    Anthony H. Goldstone;Alan Kenneth Burnett;Keith Wheatley;Alastair G. Smith

  • Presenting White Blood Cell Count and Kinetics of Molecular Remission Predict Prognosis in Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid: Result of the Randomized MRC Trial

    Alan K. Burnett;David Grimwade;Ellen Solomon;Keith Wheatley

Frequent Co-Authors

Alan Kenneth Burnett
Alan Kenneth Burnett University of Glasgow
Robert Kerrin Hills
Robert Kerrin Hills University of Oxford
Carl E Clarke
Carl E Clarke University of Birmingham
Donald Milligan
Donald Milligan University of Birmingham
Richard Gray
Richard Gray University of Oxford
Anthony H. Goldstone
Anthony H. Goldstone University College Hospital
Christopher R Burton
Christopher R Burton University of Sheffield
Nigel H. Russell
Nigel H. Russell University of Nottingham
Mary Frances McMullin
Mary Frances McMullin Queen's University Belfast
Peter J. Campbell
Peter J. Campbell Wellcome Sanger Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA can open doors to a variety of related online healthcare degrees and career opportunities. For those interested in the administrative side of healthcare, pursuing a healthcare administration associate degree online is a flexible way to start managing hospitals, clinics, or health organizations.

Nurses looking to advance their careers may consider bridging their qualifications with an asn to fnp program, which enables registered nurses to become family nurse practitioners through online learning options.

If you’re interested in nutrition and wellness, earning an online bachelor's in nutrition can help you build a rewarding career focused on dietetics, public health, or wellness coaching.

It’s crucial to ensure your chosen program is recognized for excellence. Discover which online healthcare degree programs are recognized for their accreditation by cahme? Accreditation assures quality and can impact your employment opportunities after graduation.

Best Scientists Citing Keith Wheatley

Trending Scientists

Recently Published Articles